文献速递肿瘤 PET/CT

[18F]FDG-PET/CT影像组学与人工智能在肺癌中的应用:技术要点与潜在临床应用

[18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications.
PubMed 文献 · Semin Nucl Med · 2022-06-15

本文为综述,概述[18F]FDG-PET/CT影像组学与人工智能的技术要点,并重点讨论其在非小细胞肺癌早期检测、分期、肿瘤亚型预测、生物标志物及患者结局预测中的诊断表现与作用。

要点

  • [18F]FDG-PET/CT影像组学在肺癌中的应用日益受到评估,以判断其能否提升诊断表现。
  • 本文重点讨论基于[18F]FDG-PET/CT的影像组学与非小细胞肺癌早期检测、分期、亚型及结局预测。
  • 文章为综述,技术要点部分仅作简短概述,详见本期专刊其他文章。

核心结论

  • 本文重点讨论[18F]FDG-PET/CT影像组学在非小细胞肺癌中的诊断表现及人工智能的作用,涉及早期检测、分期、肿瘤亚型预测、生物标志物与患者结局。

研究设计与样本

  • 本文为综述,简要概述本期专刊不同文章讨论的技术要点,并重点讨论[18F]FDG-PET/CT影像组学与人工智能在非小细胞肺癌中的应用。

主要发现

  • 肺癌是全球第二常见癌症及癌症相关死亡的首位原因。
  • [18F]FDG-PET/CT在肺癌诊断、治疗反应评估与结局预测中起重要作用,图像采用定性与常规定量指标评估。
  • 影像中蕴含更多信息,可通过复杂算法提取;影像组学这一概念正受到更多关注。
  • [18F]FDG-PET/CT影像组学在肺癌中日益被评估,以判断其是否增强[18F]FDG-PET/CT在肺癌管理中的诊断表现或意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung cancer is the second most common cancer and the leading cause of cancer-related death worldwide. Molecular imaging using [18F]fluorodeoxyglucose Positron Emission Tomography and/or Computed Tomography ([18F]FDG-PET/CT) plays an essential role in the diagnosis, evaluation of response to treatment, and prediction of outcomes. The images are evaluated using qualitative and conventional quantitative indices. However, there is far more information embedded in the images, which can be extracted by sophisticated algorithms. Recently, the concept of uncovering and analyzing the invisible data extracted from medical images, called radiomics, is gaining more attention. Currently, [18F]FDG-PET/CT radiomics is growingly evaluated in lung cancer to discover if it enhances the diagnostic performance or implication of [18F]FDG-PET/CT in the management of lung cancer. In this review, we provide a short overview of the technical aspects, as they are discussed in different articles of this special issue. We mainly focus on the diagnostic performance of the [18F]FDG-PET/CT-based radiomics and the role of artificial intelligence in non-small cell lung cancer, impacting the early detection, staging, prediction of tumor subtypes, biomarkers, and patient's outcomes.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Manafi-Farid R, Askari E, Shiri I, et al. [18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications. Semin Nucl Med. 2022. PMID: 35717201. doi:10.1053/j.semnuclmed.2022.04.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。